Trials / Unknown
UnknownNCT03839680
Measuring Endoscopic ACTIvity in Patients Treated With VEDOlizumab for Ulcerative Colitis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Besancon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Describe the proportion of patients with ulcerative colitis (UC) treated with vedolizumab (VDZ) who achieve mucosal healing at week 54 of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Endoscopy | The endoscopy procedure uses an endoscope to examine the interior of a hollow organ or cavity of the body. |
Timeline
- Start date
- 2018-02-01
- Primary completion
- 2019-04-15
- Completion
- 2019-04-15
- First posted
- 2019-02-15
- Last updated
- 2019-02-15
Locations
4 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03839680. Inclusion in this directory is not an endorsement.